{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:04:05Z","timestamp":1790186645759,"version":"4.1.0"},"reference-count":28,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3,1]]},"DOI":"10.1210\/jc.2015-2597","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T01:24:01Z","timestamp":1452821041000},"page":"1249-1256","source":"Crossref","is-referenced-by-count":35,"title":["Effect of Dapagliflozin With and Without Acipimox on Insulin Sensitivity and Insulin Secretion in T2DM Males"],"prefix":"10.1210","volume":"101","author":[{"given":"Aurora","family":"Merovci","sequence":"first","affiliation":[{"name":"Division of Diabetes (A.Me., M.A.-G., C.S.-H., J.X., G.D., D.T., R.A.D.), University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Abdul-Ghani","sequence":"additional","affiliation":[{"name":"Division of Diabetes (A.Me., M.A.-G., C.S.-H., J.X., G.D., D.T., R.A.D.), University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mari","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Engineering (A.Ma.), National Research Council, 35127 Padova, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Solis-Herrera","sequence":"additional","affiliation":[{"name":"Division of Diabetes (A.Me., M.A.-G., C.S.-H., J.X., G.D., D.T., R.A.D.), University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xiong","sequence":"additional","affiliation":[{"name":"Division of Diabetes (A.Me., M.A.-G., C.S.-H., J.X., G.D., D.T., R.A.D.), University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Daniele","sequence":"additional","affiliation":[{"name":"Division of Diabetes (A.Me., M.A.-G., C.S.-H., J.X., G.D., D.T., R.A.D.), University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devjit","family":"Tripathy","sequence":"additional","affiliation":[{"name":"Division of Diabetes (A.Me., M.A.-G., C.S.-H., J.X., G.D., D.T., R.A.D.), University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph A.","family":"DeFronzo","sequence":"additional","affiliation":[{"name":"Division of Diabetes (A.Me., M.A.-G., C.S.-H., J.X., G.D., D.T., R.A.D.), University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041115283984300_B1","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"Defronzo","year":"2009","journal-title":"Diabetes"},{"key":"2019041115283984300_B2","first-page":"177","article-title":"Pathogenesis of type II diabetes: metabolic and molecular implications for identifying diabetes genes","volume":"5","author":"DeFronzo","year":"1997","journal-title":"Diabetes Rev"},{"key":"2019041115283984300_B3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/jc.2003-030723","article-title":"Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus","volume":"89","author":"Bays","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115283984300_B4","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.2337\/diabetes.54.6.1640","article-title":"Dose-response effect of elevated plasma free fatty acid on insulin signaling","volume":"54","author":"Belfort","year":"2005","journal-title":"Diabetes"},{"key":"2019041115283984300_B5","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2337\/diabetes.52.10.2461","article-title":"A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes","volume":"52","author":"Kashyap","year":"2003","journal-title":"Diabetes"},{"key":"2019041115283984300_B6","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.2337\/diabetes.54.11.3148","article-title":"Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty acyl-CoAs and insulin action in type 2 diabetic patients","volume":"54","author":"Bajaj","year":"2005","journal-title":"Diabetes"},{"key":"2019041115283984300_B7","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.2337\/db13-1130","article-title":"Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals","volume":"63","author":"Daniele","year":"2014","journal-title":"Diabetes"},{"key":"2019041115283984300_B8","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.2337\/diabetes.48.9.1836","article-title":"Overnight lowering of free fatty acids with acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects","volume":"48","author":"Santomauro","year":"1999","journal-title":"Diabetes"},{"key":"2019041115283984300_B9","doi-asserted-by":"crossref","first-page":"E1775","DOI":"10.1152\/ajpendo.00624.2006","article-title":"Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes","volume":"292","author":"Cusi","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041115283984300_B10","doi-asserted-by":"crossref","first-page":"E129","DOI":"10.1152\/ajpendo.00114.2002","article-title":"Acute lowering of circulating fatty acids improves insulin secretion in a subset of type 2 diabetes subjects","volume":"284","author":"Qvigstad","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041115283984300_B11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2337\/diacare.13.6.610","article-title":"Glucose toxicity","volume":"13","author":"Rossetti","year":"1990","journal-title":"Diabetes Care"},{"key":"2019041115283984300_B12","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/BF00400466","article-title":"Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man","volume":"37","author":"Del Prato","year":"1994","journal-title":"Diabetologia"},{"key":"2019041115283984300_B13","first-page":"E251","article-title":"Effects of prolonged glucose infusion on insulin secretion, clearance, and action in normal subjects","volume":"270","author":"Boden","year":"1996","journal-title":"Am J Physiol"},{"key":"2019041115283984300_B14","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1210\/jc.2012-2097","article-title":"Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity","volume":"97","author":"Solomon","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115283984300_B15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI70704","article-title":"Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production","volume":"124","author":"Merovci","year":"2014","journal-title":"J Clin Invest"},{"key":"2019041115283984300_B16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI72227","article-title":"Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients","volume":"124","author":"Ferrannini","year":"2014","journal-title":"J Clin Invest"},{"key":"2019041115283984300_B17","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00125-014-3196-x","article-title":"Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of \u03b2-cell function in patients with type 2 diabetes","volume":"57","author":"Polidori","year":"2014","journal-title":"Diabetologia"},{"key":"2019041115283984300_B18","doi-asserted-by":"crossref","first-page":"E401","DOI":"10.1152\/ajpendo.00674.2007","article-title":"The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance","volume":"295","author":"Abdul-Ghani","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041115283984300_B19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2337\/db11-0995","article-title":"Distinct \u03b2-cell defects in impaired fasting glucose and impaired glucose tolerance","volume":"61","author":"Kanat","year":"2012","journal-title":"Diabetes"},{"key":"2019041115283984300_B20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1152\/physrev.00055.2009","article-title":"Biology of human sodium glucose transporters","volume":"91","author":"Wright","year":"2011","journal-title":"Physiol Rev"},{"key":"2019041115283984300_B21","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.2337\/diabetes.51.2007.S221","article-title":"Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation","volume":"51","author":"Mari","year":"2002","journal-title":"Diabetes"},{"key":"2019041115283984300_B22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1210\/er.2010-0029","article-title":"Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes","volume":"32","author":"Abdul-Ghani","year":"2011","journal-title":"Endocr Rev"},{"key":"2019041115283984300_B23","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1172\/JCI112981","article-title":"Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats","volume":"79","author":"Rossetti","year":"1987","journal-title":"J Clin Invest"},{"key":"2019041115283984300_B24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2265.2006.02593.x","article-title":"Insulin resistance, endocrine function and adipokines in type 2 diabetes patients at different glycaemic levels: potential impact for glucotoxicity in vivo","volume":"65","author":"Lindmark","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041115283984300_B25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/meta.2003.50041","article-title":"In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?","volume":"52","author":"Bur\u00e9n","year":"2003","journal-title":"Metabolism"},{"key":"2019041115283984300_B26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/BF00398054","article-title":"Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance","volume":"37","author":"Zierath","year":"1994","journal-title":"Diabetologia"},{"key":"2019041115283984300_B27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0026-0495(93)90079-4","article-title":"Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate","volume":"42","author":"Fulcher","year":"1993","journal-title":"Metabolism"},{"key":"2019041115283984300_B28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nm.3828","article-title":"Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic \u03b1 cells triggers glucagon secretion","volume":"21","author":"Bonner","journal-title":"Nat Med"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/3\/1249\/10429710\/jcem1249.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T05:35:47Z","timestamp":1555047347000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/101\/3\/1249\/2804938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,1]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2015-2597","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,1]]}}}